Evidence map›Paper›PMID 41676001›Full record

ArticleBio-protocol2026

Isolation and Transfection of Protoplasts From Maize Mesophyll Cells.

Lauren A Higa, Taren Bouwman, Zhi-Yan Du

Abstract read
In one paragraph

Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lauren A HigaDepartment of Molecular Biosciences & Bioengineering, University of Hawaii at Mānoa, Honolulu, HI, USA.
Taren BouwmanDepartment of Molecular Biosciences & Bioengineering, University of Hawaii at Mānoa, Honolulu, HI, USA.
Zhi-Yan DuDepartment of Molecular Biosciences & Bioengineering, University of Hawaii at Mānoa, Honolulu, HI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protoplast systems are widely used in plant research as versatile platforms for studying cellular processes and validating gene editing tools. In maize, they are particularly valuable because stable transformation in immature embryos is slow and labor-intensive, often requiring months to regenerate plants. However, existing protocols often yield inconsistent results in protoplast recovery, transfection efficiency, and viability. We present an optimized protocol for maize mesophyll protoplast isolation and PEG-mediated transfection. Two-week-old etiolated seedlings are processed using vertical cutting, improving the yield and viability of protoplasts. Protoplasts are then immediately transformed with a CRISPR/Cas9 construct after isolation, via PEG4000 with only 10 μg of plasmid DNA, reducing the resource demands of standard methods. Modified washing and storage conditions extend transformed protoplast viability to seven days, enabling longer-term monitoring and expanded downstream analyses. Editing outcomes are quantified by sequencing target sites and calculating efficiency with Cas-Analyzer. This protocol provides a rapid, efficient, and reproducible method for the rapid evaluation of gene editing in maize. This protocol offers a methodology to accelerate agricultural crop studies and broader plant molecular biology. Key features • Optimized maize mesophyll protoplast isolation using vertical cutting to improve yield, consistency, and viability. • Efficient PEG4000-mediated transformation requiring only 10 μg of plasmid DNA for CRISPR delivery. • Extended protoplast viability up to seven days through modified washing and storage conditions, enabling longer monitoring and analysis. • Rapid and reproducible gene-editing evaluation via targeted sequencing and Cas-Analyzer quantification.

Indexed as

CRISPRMaizeMesophyllProtoplastTransformation

Identifiers

PMID41676001
PMCPMC12887867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.